Introduction

Following our successful collaboration with the Swedish Pharmaceutical Society in Gothenburg last year, the 48th DMDG Open Meeting sees us back at the familiar location of Robinson College, University of Cambridge, UK. As in 2017, we again have exclusive use of the fantastic Crausaz Wordsworth Building which will be the hub of this year’s meeting, with registration, poster session, trade exhibition and associated drinks reception, tea/coffee and lunch breaks taking place here for the duration of the meeting.

The meeting kicks off with a Keynote Lecture by Dr Richard Peck, Head of Clinical Pharmacology at Roche, followed by sessions covering biologics biotransformation and the importance of the gut microbiome, together with the popular poster blitz session. Sessions on the following days will include PEGylated protein development, AI in DMPK, drug discovery in the ‘Beyond rule of 5’ space, QSP and PBPK modelling approaches, challenges associated with development of orally dosed biologicals and a free communications session.

Following the success of the newly revived debate in Gothenburg last year, DMDG fellow Dr Steve Hood will reprise his role as host to a new panel of experts debating the relative merits of different bioimaging techniques.

Further discussion and networking will be encouraged at our evening events, to include the poster session reception and conference dinner with entertainment to follow – you won’t want to miss it! Further details of all sessions and events are provided in the attached conference programme – we look forward to welcoming you at what promises to be a great event!

For sponsorship opportunities for this event, please download this document.

This meeting is sponsored by: